TRIB2 and acute lymphoblastic leukemia: Similar to our data showing that the loss of Trib2 results in disease penetrance of 100%, the absence of the tumor suppressor PTEN [41] or expression of oncogenic KRAS [24] both increase penetrance and decrease the latency of T-ALL induced by L1601PΔP.